PFANSTIEL STEVEN (CFO) sold 5.5% of their position (4.66K shares) of MARINUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $5.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/7/2024ACC: 0001415889-24-020898
Officer· CFO
Since Apr 2021
-4.66K
Net shares
Net seller
$5.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.66K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.66K
Price / share
$1.13
Trade value
$5.26K
% of position
5.5%
8/5/2024
84.43K→79.77K
Total
Net shares
−4.66K
Net value
-$5.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/5/2024 | S · Sale | −4.66K | $1.13 | $5.26K | 5.5% | 84.43K | 79.77K |
| Total | −4.66K | -$5.26K | ||||||
Derivative Transactions0
No derivative transactions reported